MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E Macro Group Pharmaceuticals (Macro Capital) S.A.E Share Price
Equities
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.01 EGP | +3.61% |
|
0.00% | -31.86% |
| Sales 2022 | 730M 15.17M 1.21B | Sales 2023 | 526M 10.94M 872M | Capitalization | 1.68B 34.97M 2.79B |
|---|---|---|---|---|---|
| Net income 2022 | 174M 3.62M 288M | Net income 2023 | -273M -5.68M -452M | EV / Sales 2022 | 2.59 x |
| Net Debt 2022 | 16.96M 353K 28.11M | Net Debt 2023 | 151M 3.14M 250M | EV / Sales 2023 | 3.48 x |
| P/E ratio 2022 |
10.9
x | P/E ratio 2023 |
-6.1
x | Employees | - |
| Yield 2022 |
3.25% | Yield 2023 |
-
| Free-Float | 27.02% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.61% | ||
| Current month | -4.29% | ||
| 1 month | -5.63% | ||
| 3 months | -31.16% | ||
| 6 months | -35.16% | ||
| Current year | -31.86% |
1 month
1.91
2.24
Current year
1.913.84
1 year
1.913.84
3 years
1.915.28
5 years
1.915.28
10 years
1.915.28
| Managers | Title | Age | Since |
|---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 30/11/19 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 30/06/19 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 31/12/20 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 31/12/20 |
Ahmed El-Nayeb
FOU | Founder | - | 31/12/01 |
Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.
At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.01
EGP
Average target price
5.3
EGP
Spread / Average Target
+163.68%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.86% | 23.72M | |
| +51.63% | 796B | |
| +41.51% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.66% | 244B | |
| +3.39% | 228B | |
| +10.75% | 214B | |
| +6.99% | 165B |
- Stock Market
- Equities
- MCRO Stock
